Pharmacogenomic blood-based assay to predict chemotherapy response and survival in pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.738
Abstract: 738Background: Pancreatic adenocarcinoma (PDAC) is for most patients a refractory disease. Modern cytotoxic chemotherapeutics (C) are not yet optimal for inducing responses and extending life. We a... read more here.
Keywords: chemotherapy response; pharmacogenomic blood; assay predict; blood based ... See more keywords